NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-HD-19-021 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-071 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-19-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) requests applications for the Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers Program. The HCCC is expected to work collaboratively with 4-5 Cooperative Centers of Excellence in Hematology (CCEHs) as part of the NIDDK Hematology Centers Program and serve as a national resource for the larger nonmalignant hematology research community. The HCCC will provide central administrative and communications support for the NIDDK Hematology Centers Program and operate a Pilot and Feasibility Program, supporting pilot research studies that will lead to larger research projects. All activities within the Program are expected to address the overall goal of supporting the national multidisciplinary research effort to combat nonmalignant hematologic diseases and/or tostudy normal hematopoiesis.
Notice NOT-HD-19-029 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-070 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-069 from the NIH Guide for Grants and Contracts
Notice NOT-EB-19-021 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-373 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) solicits research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Both animal and human subjects research projects are welcome. Researchers proposing basic science experimental studies involving human participants should consider this FOAs companion for basic experimental studies with humans.
Funding Opportunity PAR-19-384 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) solicits research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of projects submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena related to social connectedness and isolatedness. NIH considers such studies as prospective basic science studies involving human participants that meet the NIH definition of basic research and fall within the NIH definition of a clinical trials (see, e.g., NOT-OD-19-024)
Funding Opportunity RFA-HD-20-019 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage small businesses to collaborate with scientists and clinicians in the field of gynecologic health to develop, advance, and validate new devices and methods for non-invasive diagnosis and/or screening of endometriosis, adenomyosis, and/or uterine fibroids. Projects supported will aim to shorten the time to diagnosis, decrease the invasiveness of current techniques, and/or improve accessibility, safety, convenience, and costs of diagnosis and/or screening.
Funding Opportunity RFA-HD-20-008 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage the use of a phased research approach to generate information needed to develop interventions to reduce long-term effects of in utero exposure to antiretroviral therapy (ART) and/or HIV on health outcomes. This FOA will support two-phased research applications to (1) demonstrate the capacity to enroll sufficient numbers of HIV-exposed uninfected (HEU) infants, children, adolescents, and/or young adults in the United States and/or international settings with high HIV burden, and then, to (2) utilize the established cohort with innovative epidemiological approaches to conduct research.
Notice NOT-MH-19-051 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-380 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities that The overarching goal of this NHGRI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in genomics. This funding opportunity announcement seeks to expose underrepresented students at the undergraduate, post-baccalaureate and graduate levels to the foundational sciences relevant to genomics to enable them to pursue careers that span all areas of interest to NHGRI - genome sciences, genomic medicine and genomics and society. For the purposes of this FOA, the term genomics encompasses issues and activities in these three areas of genomic research.
Funding Opportunity PAR-19-381 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.
Funding Opportunity PAR-19-382 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.
Funding Opportunity RFA-ES-20-003 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate multidisciplinary research projects studying the effects of environmental chemicals on maternal physiology, and endocrine and metabolic functions during and shortly after pregnancy, as well as potential long-term maternal health effects caused by environmental exposures.
Funding Opportunity RFA-DA-20-026 from the NIH Guide for Grants and Contracts. The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.
Notice NOT-OD-19-146 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-383 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that complement and/or enhance the training of a diverse workforce to meet the nations biomedical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on skills development, mentoring, and outreach to equip a diverse cohort of participants with the technical, operational, and professional skills required for careers in the biomedical research workforce. Funded programs are expected to have robust evaluation, dissemination, and sustainability plans.
Funding Opportunity RFA-CA-19-054 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is a continuation of Cancer Intervention and Surveillance Modeling Network (CISNET - https://cisnet.cancer.gov) program. This FOA invites applications for collaborative research projects using simulation and other modeling techniques for specific cancer types (see below). The proposed research is expected to generate sophisticated, evidence-based decision tools that could inform international/national/regional/local decisions on the most efficient utilization of existing and emerging technologies and strategies for the control of cancer